Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong · Delayed Price · Currency is HKD 5.65
+0.02 (0.36%)
Sep 18, 2026, 4:08 PM HKT
HKG:3613 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:3613 stock has a consensus rating of "Buy" and an average price target of $9.75. The average 1-year stock price forecast is 72.72% higher than the current stock price, while the lowest is $9.00 (+59.43%) and the highest is $10.50 (+86.01%).
Price Target: $9.75 (+72.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3613 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Dec '25 | Mar '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.50 | Buy | Maintains | $10.50 | +86.01% | Sep 1, 2026 |
Financial Forecast
Revenue This Year
1.48B
from 1.51B
Decreased by -2.05%
Revenue Next Year
1.66B
from 1.48B
Increased by 11.81%
EPS This Year
0.53
from 0.47
Increased by 12.77%
EPS Next Year
0.59
from 0.53
Increased by 11.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is HKD.